Clinical Scorecard: Immunological Responses in Intra-Abdominal Infections: Transitioning from Peritoneal Defense Mechanisms to Systemic Sepsis
At a Glance
Category
Detail
Condition
Complicated intra-abdominal infection (cIAI) and intra-abdominal sepsis (IAS)
Key Mechanisms
Specialized peritoneal immune compartment with resident macrophages, B1 cells, innate lymphoid cells, and fat-associated lymphoid clusters enabling rapid local inflammatory response; progression to systemic sepsis via peritoneal barrier failure and dissemination of pathogen- and injury-associated signals
Target Population
Patients with complicated intra-abdominal infections, especially those with risk factors such as advanced age, immunosuppression, comorbidities, and high disease severity
Care Setting
Emergency and general surgery, critical care settings managing acute abdominal emergencies and sepsis
Key Highlights
cIAI frequently progresses rapidly to IAS, characterized by early organ dysfunction and poor outcomes.
The peritoneal cavity is an active immune compartment with specialized cells and structures that mount rapid local responses to infection.
Failure of local immune containment leads to systemic inflammatory-immune imbalance and sepsis progression.
Guideline-Based Recommendations
Diagnosis
Classify intra-abdominal infections as uncomplicated or complicated based on infection confinement.
Recognize clinical signs of cIAI including acute abdominal pain, peritoneal irritation, systemic inflammation, and organ dysfunction.
Use risk stratification incorporating host factors and disease severity to identify progression to IAS.
Management
Implement timely surgical or interventional source control to address the infection focus.
Administer early empiric broad-spectrum antimicrobial therapy.
Provide organ-supportive care tailored to disease severity and patient condition.
Monitoring & Follow-up
Monitor for signs of hemodynamic instability, elevated lactate, and organ dysfunction indicating progression to IAS.
Use clinical scoring systems such as WSES cIAI Score to assess sepsis severity and mortality risk.
Risks
Delayed or insufficient intervention increases risk of peritoneal barrier failure and systemic sepsis.
Host factors including advanced age, immunosuppression, and comorbidities worsen prognosis.
High microbial burden and exaggerated local immune responses contribute to disease escalation.
Patient & Prescribing Data
Patients with complicated intra-abdominal infections requiring urgent surgical and antimicrobial treatment
Early multimodal intervention combining source control and broad-spectrum antibiotics is critical to prevent progression to sepsis and reduce mortality.
Clinical Best Practices
Adopt a compartment-oriented immunopathological framework to understand and manage cIAI and IAS.
Integrate early risk stratification based on immune and clinical parameters to guide treatment intensity.
Combine surgical source control with immunologically informed, stratified therapeutic strategies.
